Cencora (WBO:ABC) Beginning Cash Position: €1,543 Mil (As of Mar. 2026)


WBO:ABC Cencora Inc WBO:ABC
68 GF Score
Price €271.70
GF Value €256.66
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Beginning Cash Position?

Cencora WBO:ABC +1.27% 68 Beginning Cash Position is €1,543 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 68/100 and a GF Value™ of €256.66 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's Beginning Cash Position for the quarter that ended in Mar. 2026 was €1,543 Mil.

Cencora's quarterly Beginning Cash Position increased from Sep. 2025 (€1,939 Mil) to Dec. 2025 (€3,753 Mil) but then declined from Dec. 2025 (€3,753 Mil) to Mar. 2026 (€1,543 Mil).

Cencora's annual Beginning Cash Position declined from Sep. 2023 (€3,367 Mil) to Sep. 2024 (€2,480 Mil) but then increased from Sep. 2024 (€2,480 Mil) to Sep. 2025 (€2,810 Mil).

Cencora Beginning Cash Position Related Terms

Cencora Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Cencora's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Beginning Cash Position Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,906.60 3,100.21 3,367.15 2,480.35 2,809.80

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,140.35 1,888.82 1,938.58 3,752.95 1,543.34
WBO:ABC
68GF Score
Cencora Inc WBO:ABC
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €1,543 Mil mean?
Cencora (WBO:ABC) has a Beginning Cash Position of €1,543 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Cencora and its competitors.
Is Cencora's Beginning Cash Position too high?
Cencora's current Beginning Cash Position is €1,543 Mil. Overall, Cencora has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Beginning Cash Position compare to CAH and MCK?
Cencora's Beginning Cash Position of €1,543 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Distribution company?
A good Beginning Cash Position depends on the Medical Distribution industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Cencora and its competitors. Cencora's current Beginning Cash Position is €1,543 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €256.66, compared to a current price of €271.70 — trading 5.9% above its estimated fair value. The current Beginning Cash Position is €1,543 Mil. Cencora's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Beginning Cash Position is €1,543 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of €271.70 is trading 5.9% above its estimated GF Value™ of €256.66. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Beginning Cash Position: €1,543 Mil
  • GF Value™: €256.66 vs. price of €271.70 (5.9% above fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
68GF Score

Get the complete analysis for WBO:ABC

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€271.70
Price
€256.66
GF Value